Editorial: Targeted Therapy for Pituitary Adenomas

Takako Araki; Odelia Cooper; Hidenori Fukuoka

doi:10.3389/fendo.2019.00358

Editorial: Targeted Therapy for Pituitary Adenomas

Front Endocrinol (Lausanne). 2019 Jun 4:10:358. doi: 10.3389/fendo.2019.00358. eCollection 2019.

Authors

Takako Araki¹, Odelia Cooper², Hidenori Fukuoka³

Affiliations

¹ Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.
² Pituitary Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
³ Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe, Japan.

No abstract available

Keywords: Cushing's disease; Dopamin agonists; Somatostatin agonists; aggressive pituitary tumor; molecular targeted agents; pituitary tumors; targeted therapeutic.

Publication types

Editorial